title: [Prognostic and predictively relevant factors for multiple sclerosis].
abstract: The immunotherapy of multiple sclerosis (MS) is currently one of the most dynamic fields in clinical neurology. The comprehensive number of well-established and new innovative treatment options are a challenge for an intensive preoccupation with the differential indications and an activity-driven treatment control. In this context this review summarizes the known predictors of the natural course of MS and gives a review of challenges to be expected in association with predictors of treatment control.
authors.affiliation: Klinik für Neurologie, Bereich Neuroimmunologie, AG Klinische Neuroimmunologie, Philipps-Universität und Universitätsklinikum Marburg, Baldingerstr. 1, 35043, Marburg, Deutschland, tackenbb@Staff.Uni-Marburg.de.
authors.forename: B
authors.initials: B
authors.lastname: Tackenberg
authors.forename: T
authors.initials: T
authors.lastname: Schneider-Hohendorf
authors.forename: A
authors.initials: A
authors.lastname: Müller
authors.forename: J
authors.initials: J
authors.lastname: Schodrowski
authors.forename: H
authors.initials: H
authors.lastname: Wiendl
mesh_terms: D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015994:Incidence; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods; D016896:Treatment Outcome